Sign In
Buy TIVC
$0.258
+0 (+0%)
At Close: Jul 31, 2026
Tivic Reports Third Quarter 2025 Financial Results
04:30pm, Friday, 14'th Nov 2025
Continues Execution of Strategic Transformation and Advancement of Biologics Pipeline FREMONT, CA / ACCESS Newswire / November 14, 2025 / Tivic Health® Systems, Inc. (Nasdaq:TIVC), a diversified immu
Tivic Health Reports Findings of Clinical Optimization Trial of Non-Invasive Cervical Vagus Nerve Stimulation (ncVNS)
08:30am, Thursday, 13'th Nov 2025
The study demonstrated that personalizing the stimulation parameters to each user dramatically enhanced autonomic effects FREMONT, CA / ACCESS Newswire / November 13, 2025 / Tivic Health Systems, Inc.
Tivic Expands Intellectual Property Portfolio
09:00am, Monday, 10'th Nov 2025
FREMONT, Calif.--(BUSINESS WIRE)--Tivic Health® Systems, Inc. (Nasdaq: TIVC), a diversified therapeutics company, today announced it is expanding its intellectual property portfolio with the recent f
Tivic Health to Report Third Quarter 2025 Financial Results on November 14th Via Conference Call and Webcast
09:30am, Thursday, 06'th Nov 2025
FREMONT, Calif.--(BUSINESS WIRE)--Tivic Health® Systems, Inc. (Nasdaq: TIVC), a diversified immunotherapeutics company, today announced that it will report its third quarter results for 2025 via pre-
Tivic CEO, Jennifer Ernst, to Join Panel at 8th Annual Northwell Health Innovation Constellation Forum on Thursday, Oct. 23
02:00pm, Wednesday, 22'nd Oct 2025
FREMONT, Calif.--(BUSINESS WIRE)--Tivic Health® Systems, Inc. (Nasdaq: TIVC), a diversified immunotherapeutics company, today announced that CEO, Jennifer Ernst, will participate in the eighth annual
Tivic Health CEO Jennifer Ernst to Present at Emerging Growth's September Virtual Conference
08:30am, Monday, 22'nd Sep 2025
FREMONT, Calif.--(BUSINESS WIRE)--Tivic Health® Systems, Inc. (Nasdaq: TIVC), a diversified immunotherapeutics company, today announced that the company's CEO will present during the Emerging Growth
Tivic Completes Verification of Entolimod™ Cell Line: First Step in Establishing CGMP Manufacturing for BLA Filing
08:30am, Wednesday, 10'th Sep 2025
FREMONT, Calif.--(BUSINESS WIRE)--Tivic Health® Systems, Inc. (Nasdaq: TIVC), a diversified immunotherapeutics company, today announced that it has completed verification of its Entolimod™ cell lin
FREMONT, Calif.--(BUSINESS WIRE)--Tivic Health® Systems, Inc. (Nasdaq: TIVC), a diversified immunotherapeutics company, today announced it has received, from Statera Biopharma, two investigational ne
FREMONT, Calif.--(BUSINESS WIRE)--Tivic Health® Systems, Inc. (Nasdaq: TIVC), a diversified therapeutics company, is proud to announce it advanced discussions with key US Government agencies through
Tivic Health Systems, Inc. (TIVC) Q2 2025 Earnings Call Transcript
07:59pm, Thursday, 14'th Aug 2025
Tivic Health Systems, Inc. (NASDAQ:TIVC ) Q2 2025 Earnings Conference Call August 14, 2025 4:30 PM ET Company Participants Jennifer Ernst - Co-Founder, CEO & Director Lisa G. Wolf - CFO and Principal
Tivic Health (TIVC) Q2 2025 Earnings Transcript
05:02pm, Thursday, 14'th Aug 2025
Image source: The Motley Fool.
Tivic Reports Second Quarter 2025 Financial Results
04:00pm, Thursday, 14'th Aug 2025
FREMONT, Calif.--(BUSINESS WIRE)--Tivic Health® Systems, Inc. (NASDAQ: TIVC), a diversified immunotherapeutics company, today announced financial results for the second quarter and six months ended J
Tivic Health to Report Second Quarter 2025 Financial Results on August 14th Via Conference Call and Webcast
08:30am, Thursday, 07'th Aug 2025
FREMONT, Calif.--(BUSINESS WIRE)--Tivic Health® Systems, Inc. (Nasdaq: TIVC), a diversified immunotherapeutics company developing treatments that stimulate immune pathways to treat disease, today ann
Tivic Shareholders Approve Key Proposals in Support of Strategic Transformation; Lisa Wolf Appointed Permanent CFO
08:30am, Tuesday, 08'th Jul 2025
FREMONT, Calif.--(BUSINESS WIRE)--Tivic Health® Systems, Inc. (Nasdaq: TIVC), a diversified immunotherapeutics company, today announced that key proposals needed to carry out the company's strategic
Tivic Health Completes Optimization Study for Its Non-Invasive Vagus Nerve Stimulation Device
08:30am, Wednesday, 25'th Jun 2025
FREMONT, Calif.--(BUSINESS WIRE)--Tivic Health® Systems, Inc. (Nasdaq: TIVC), a diversified immunotherapeutics company developing treatments that stimulate immune pathways to treat disease, today ann
